Saturday, 21 November 2026European Markets

ULTIMOVACS Stock 26.4% Up On Wednesday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - The Market ended the session with ULTIMOVACS (ULTI.OL) jumping 26.4% to kr11.06 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.48% to kr1,349.28.

ULTIMOVACS's last close was kr8.75, 95.1% under its 52-week high of kr178.60.

About ULTIMOVACS

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.5.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -51.94%.

Yearly Top and Bottom Value

ULTIMOVACS's stock is valued at kr11.06 at 22:30 EST, way below its 52-week high of kr178.60 and way above its 52-week low of kr6.07.

Moving Average

ULTIMOVACS's worth is way below its 50-day moving average of kr106.48 and way under its 200-day moving average of kr97.64.

Volatility

ULTIMOVACS's last week, last month's, and last quarter's current intraday variation average was a positive 9.79%, a negative 0.65%, and a positive 3.55%.

ULTIMOVACS's highest amplitude of average volatility was 9.79% (last week), 6.29% (last month), and 3.55% (last quarter).

Volume

Today's last reported volume for ULTIMOVACS is 6394220 which is 513.6% above its average volume of 1042080.

More news about ULTIMOVACS (ULTI.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 3 Apr 2024
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›